• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人绒毛膜促性腺激素及促性腺激素释放激素及其受体在子宫内膜癌和增生中的表达。

Expression of hCG and GnRHs and their receptors in endometrial carcinoma and hyperplasia.

机构信息

Department of Cell Biology, Poznan University of Medical Sciences, Poznan, Poland.

出版信息

Int J Gynecol Cancer. 2010 Jan;20(1):92-101. doi: 10.1111/IGC.0b013e3181bbe933.

DOI:10.1111/IGC.0b013e3181bbe933
PMID:20130508
Abstract

OBJECTIVES

Recent studies propose the role of gonadotropins in the development and growth of endometrial carcinoma. The present research was undertaken to establish the expression of human chorionic gonadotropin (hCG), gonadotropin-releasing hormones 1 (GnRH1 and GnRH2, respectively) and their receptors in endometrial hyperplasias and carcinoma.

MATERIAL AND METHODS

The expression of analyzed genes in endometrial carcinoma and hyperplasia with and without atypia was evaluated using reverse transcriptase polymerase chain reaction and immunohistochemistry.

RESULTS

The results of the experiments demonstrated the presence of hCG and GnRH1 at both messenger RNA and protein levels in endometrial carcinoma and atypical hyperplasia. Noncancerous tissue and hyperplasia without atypia demonstrated the lack of these gene coexpressions. The expression of GnRH2, LH/hCGR, and GnRHRs was heterogeneous, and the study molecules were found only in part of the analyzed tissues. The presence of hCG and GnRH1 and their receptors in cancer tissue and atypical hyperplasia suggests autocrine/paracrine action of hormones regulating the endometrial carcinoma cell proliferation.

CONCLUSIONS

The interaction between the hCG and LH/hCGR in endometrial tissue might stimulate cell growth and promote neoangiogenesis, whereas GnRHs, by binding to their receptors, could be responsible for the antiproliferative effect and stimulation of apoptosis. The identification of differences in the expression profile of the analyzed genes could be relevant for better understanding of the development of endometrial carcinomas and could be useful in clinical diagnostics.

摘要

目的

最近的研究表明促性腺激素在子宫内膜癌的发生和发展中起作用。本研究旨在建立人绒毛膜促性腺激素(hCG)、促性腺激素释放激素 1(GnRH1 和 GnRH2)及其受体在子宫内膜增生和癌中的表达。

材料与方法

采用逆转录聚合酶链反应和免疫组织化学方法检测分析基因在子宫内膜癌和伴或不伴非典型性增生中的表达。

结果

实验结果表明 hCG 和 GnRH1 在子宫内膜癌和非典型性增生的信使 RNA 和蛋白水平上均有表达。非癌组织和无异型性增生缺乏这些基因的共表达。GnRH2、LH/hCGR 和 GnRHRs 的表达具有异质性,研究分子仅存在于部分分析组织中。hCG 和 GnRH1 及其受体在癌组织和非典型性增生中的存在提示激素的自分泌/旁分泌作用调节子宫内膜癌细胞的增殖。

结论

hCG 和 LH/hCGR 在子宫内膜组织中的相互作用可能刺激细胞生长并促进新血管生成,而 GnRHs 通过与其受体结合可能对增殖产生抑制作用并刺激细胞凋亡。分析基因表达谱的差异可能有助于更好地了解子宫内膜癌的发生,并可能有助于临床诊断。

相似文献

1
Expression of hCG and GnRHs and their receptors in endometrial carcinoma and hyperplasia.人绒毛膜促性腺激素及促性腺激素释放激素及其受体在子宫内膜癌和增生中的表达。
Int J Gynecol Cancer. 2010 Jan;20(1):92-101. doi: 10.1111/IGC.0b013e3181bbe933.
2
Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas.黄体生成素/人绒毛膜促性腺激素受体基因在人子宫内膜癌中的表达增加。
J Clin Endocrinol Metab. 1994 Nov;79(5):1483-91. doi: 10.1210/jcem.79.5.7962347.
3
Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women.无排卵女性子宫内膜增生和癌组织中LH/hCG受体表达增加。
Gynecol Oncol. 1997 May;65(2):273-80. doi: 10.1006/gyno.1997.4656.
4
Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium.促性腺激素释放激素受体及其信使核糖核酸在子宫内膜癌和子宫内膜中的存在情况。
Gynecol Oncol. 1994 Oct;55(1):144-8. doi: 10.1006/gyno.1994.1264.
5
[Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues].[卵巢癌组织中促黄体生成素(LH)/人绒毛膜促性腺激素(hCG)受体(LH/hCGR)及hCG蛋白表达的评估]
Ginekol Pol. 2007 Dec;78(12):939-43.
6
Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.von Hippel-Lindau 基因在人子宫内膜增生症和子宫内膜癌中的异常表达。
Int J Gynecol Cancer. 2011 Apr;21(3):430-4. doi: 10.1097/IGC.0b013e31820c5903.
7
Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: could it be a new marker?人绒毛膜促性腺激素在子宫内膜增生和子宫内膜癌中的表达:它会是一种新的标志物吗?
Int J Gynecol Cancer. 2023 May 1;33(5):707-712. doi: 10.1136/ijgc-2023-004279.
8
Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.子宫内膜癌中CD24表达增强及其在正常和增生期子宫内膜中的表达模式。
Histol Histopathol. 2009 Mar;24(3):309-16. doi: 10.14670/HH-24.309.
9
Expression and distribution of GnRH, LH, and FSH and their receptors in gastrointestinal tract of man and rat.促性腺激素释放激素、促黄体生成素和促卵泡生成素及其受体在人和大鼠胃肠道中的表达与分布
Regul Pept. 2013 Nov 10;187:24-8. doi: 10.1016/j.regpep.2013.09.002. Epub 2013 Oct 6.
10
Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.细胞视黄醇结合蛋白-1在子宫内膜增生和癌中的表达:诊断及可能的治疗意义
Mod Pathol. 2006 Jun;19(6):797-803. doi: 10.1038/modpathol.3800586.

引用本文的文献

1
Role of gonadotropin-releasing hormone 2 and its receptor in human reproductive cancers.促性腺激素释放激素 2 及其受体在人类生殖系统癌症中的作用。
Front Endocrinol (Lausanne). 2024 Jan 8;14:1341162. doi: 10.3389/fendo.2023.1341162. eCollection 2023.
2
Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).卵巢癌的激素治疗:强调机制与应用(综述)。
Oncol Rep. 2021 Oct;46(4). doi: 10.3892/or.2021.8174. Epub 2021 Aug 26.
3
The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer.促性腺激素释放激素(GnRH)在子宫内膜癌中的作用。
Cells. 2021 Feb 1;10(2):292. doi: 10.3390/cells10020292.
4
Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.人绒毛膜促性腺激素β调节人卵巢癌中的上皮-间质转化和转移。
Oncol Rep. 2017 Sep;38(3):1464-1472. doi: 10.3892/or.2017.5818. Epub 2017 Jul 14.
5
Influence of VEGFR and LHCGR on endometrial adenocarcinoma.血管内皮生长因子受体(VEGFR)和促黄体生成素/绒毛膜促性腺激素受体(LHCGR)对子宫内膜腺癌的影响。
Oncol Lett. 2016 Sep;12(3):2092-2098. doi: 10.3892/ol.2016.4906. Epub 2016 Jul 22.
6
Effects of HCG on human epithelial ovarian cancer vasculogenic mimicry formation .人绒毛膜促性腺激素对人上皮性卵巢癌血管生成拟态形成的影响
Oncol Lett. 2016 Jul;12(1):459-466. doi: 10.3892/ol.2016.4630. Epub 2016 May 25.
7
Involvement of human chorionic gonadotropin in regulating vasculogenic mimicry and hypoxia-inducible factor-1α expression in ovarian cancer cells.人绒毛膜促性腺激素参与调节卵巢癌细胞中的血管生成拟态和缺氧诱导因子-1α表达。
Cancer Cell Int. 2016 Jun 24;16:50. doi: 10.1186/s12935-016-0327-0. eCollection 2016.
8
Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model.LH 受体过表达增加子宫内膜癌小鼠模型的远处转移。
Front Oncol. 2013 Nov 19;3:285. doi: 10.3389/fonc.2013.00285. eCollection 2013.
9
Human chorionic gonadotropin beta subunit genes CGB1 and CGB2 are transcriptionally active in ovarian cancer.人绒毛膜促性腺激素β亚基基因CGB1和CGB2在卵巢癌中具有转录活性。
Int J Mol Sci. 2013 Jun 17;14(6):12650-60. doi: 10.3390/ijms140612650.
10
CGB and GNRH1 expression analysis as a method of tumor cells metastatic spread detection in patients with gynecological malignances.CGB 和 GNRH1 表达分析作为检测妇科恶性肿瘤患者肿瘤细胞转移扩散的方法。
J Transl Med. 2011 Aug 9;9:130. doi: 10.1186/1479-5876-9-130.